港股異動丨廣汽集團(2238.HK)漲4.28% 8月汽車銷量18.06萬輛 同比增長11.64%
格隆匯9月9日丨廣汽集團(2238.HK)漲4.28%,報6.82港元,總市值698一港元;廣汽集團(601238.SH)則微跌0.19%。

廣汽集團(02238.HK)披露2020年8月份產銷快報,當月汽車產量166,315輛,同比增長7.82%;當月汽車銷量180,609輛,同比增長11.64%。1-8月累計汽車產量1,165,947輛,同比下降8.11%;1-8月累計銷量1,189,125輛,同比下降9.87%。
汽車板塊內其它個股則普跌,吉利和比亞迪均跌約3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.